SynthesisBMC infectious diseases2026
The association between Helicobacter pylori infection and asthma risk: an updated systematic review and meta-analysis.
Synthesis in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough Helicobacter pylori (H. pylori) has been hypothesized to modulate immune responses in the context of asthma, recent epidemiological evidence has yielded contradictory results. This updated meta-analysis systematically re-evaluates the association between H. pylori infection and asthma risk to clarify these discrepancies.
methodsA systematic review and meta-analysis were conducted following PRISMA 2020 guidelines. We systematically searched PubMed, Web of Science, Cochrane Library, and Embase up to February 2026 to identify eligible observational studies. To evaluate the risk association, pooled odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated, utilizing either fixed- or random-effects models contingent upon the degree of statistical heterogeneity.
results43 studies encompassing 240,715 individuals were included. Stratification by study design yielded diverging results: retrospective case-control studies indicated a significant inverse association (OR 0.78, 95% CI 0.63-0.95), whereas prospective cohort data suggested a positive association with asthma incidence (HR 1.13, 95% CI 1.07-1.19). Furthermore, subgroup analyses identified a robust inverse association in individuals infected with high-virulence CagA-positive strains (OR 0.75, 95% CI 0.62-0.90), which remained consistent across different study designs. In contrast, the inverse association observed in pediatric populations (OR 0.60, 95% CI 0.46-0.79) appeared sensitive to the underlying study design and diagnostic framework.
conclusionIn conclusion, the H. pylori-asthma association is highly dependent on study design and clinical context. While overall results remain uncertain due to diverging retrospective and prospective findings, we identified a robust inverse association in CagA-positive groups that is consistent across study designs. In contrast, findings in pediatric populations are sensitive to methodological variations, necessitating cautious interpretation. These results indicate H. pylori does not exert a uniform effect; rather, the relationship is likely moderated by pathogen virulence and host factors. Consequently, our findings warrant significant caution, and future prospective research is essential to determine their clinical relevance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.